Pharmacoeconomic evaluation of artesunate-amodiaquine and artesunate- mefloquine artemisinin-based combination therapies.

ABSTRACT

These two artemisinin-combination therapies (ACTs) have been found to be rarely prescribed due to various reasons relating to both clinical and marketing promotional considerations. This study aims at uniting these factors by evaluating the pharmacoeconomic considerations on the choice of these two drugs. Published data on efficacy/ effectiveness trials were reviewed from where the data for this study were extracted. A pharmacoeconomic analysis was carried out using the various tools of pharmacoeconomics. It was found out that clinically derivable utilities and health outcomes (Side-effects and, probably, convenience of dosage regimen) did not favour the frequent choice of these drugs. Side effects and, probably, convenience of dosage regimen mainly affected the choice of these drugs.Clinical cure should not be the only health outcome to be guided in therapy. Other unfavourable health outcomes should be considered also. Disability/Distress to the patients should be considered also. However, Artesunate-Amodiaquine (AAQ) has a superior pharmacoeconomic advantage over Artesunate-Mefloquine (AM) in terms of cost and cost utility. Artesunate-Mefloquine (AM) has a higher cost-benefit than AAQ but this is rarely used in health considerations. Side effects of these drugs limit their choice as antimalarials. in effective in treating uncomplicated Plasmodium falciparum malaria

KEYWORDS

• Pharmacoeconomics
• health outcomes
• disability/distress scale
• recrudescence
• health utility

Showing references and in-text citations exactly as published.

RELATED ARTICLES

Matched on section and article type within this issue of IJPP.

• Article · VOLUME 2, ISSUE 3Retrospective Patient Data Analysis with Respect to Irresponsible SelfMedication in a Community Pharmacy Setting in Taiping (Malaysia)Sam A T, Naga Jothy Nagesvararao, Nager Devi Vampanan, Sharon T X X S, Arumugam D · pp. 19–30Research ArticleSame type: Article
• Article · VOLUME 2, ISSUE 3Impact on the outcome of pharmacotherapy of senior Indian inpatients: A pharmacist led interventionMandavi M, Padmavathi R, Mangu R, Pramil T, Vinay K · pp. 31–37Research ArticleSame type: Article
• Article · VOLUME 2, ISSUE 3Impact of patient education on health related quality of life of dialysis patientsRamani G.K., Dholakiya R.B, Patel G.F · pp. 38–41Research ArticleSame type: Article
• Article · VOLUME 2, ISSUE 3Safety and efficacy of amiodarone in arrhythmias – a prospective study in the South Indian populationVasantha Janardhan, Kousalya K, Ramalakshmi S, Vanitha Rani N, Kannan G, Jyothsna G, Uma M R C · pp. 42–47Research ArticleSame type: Article